MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole.
about
Proteomics As a Tool for Studying Bacterial Virulence and Antimicrobial ResistanceRapid clinical bacteriology and its future impactRapid species diagnosis for invasive candidiasis using mass spectrometryMALDI-TOF mass spectrometry proteomic phenotyping of clinically relevant fungi.Matrix-assisted laser desorption ionization-time of flight mass spectrometry for the identification of clinically relevant bacteria.Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours.Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species.Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals.What is new in clinical microbiology-microbial identification by MALDI-TOF mass spectrometry: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology.Emerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient management.MALDI-TOF-MS-based species identification and typing approaches in medical mycology.Advances in identification of clinical yeast isolates by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry.MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond.Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis.MALDI-TOF MS: an upcoming tool for rapid detection of antibiotic resistance in microorganisms.MALDI-TOF mass spectrometry: any use for Aspergilli?MALDI-TOF MS-based identification of black yeasts of the genus Exophiala.Detection of triazole resistance among Candida species by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS).Detection of yeasts in blood cultures by the Luminex xTAG fungal assay.Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for rapid identification of mold and yeast cultures of Penicillium marneffei.Performance of MALDI-TOF MS platforms for fungal identification.Antifungal Susceptibility Testing of Aspergillus spp. by Using a Composite Correlation Index (CCI)-Based Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Method Appears To Not Offer Benefit over Traditional Broth MicrodilNext-generation antimicrobial susceptibility testing.The future of fungal susceptibility testing.Mass spectrometry applications in microbiology beyond microbe identification: progress and potential.Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification.Rapid detection of fluconazole resistance in Candida tropicalis by MALDI-TOF MS.Pushing the Limits of MALDI-TOF Mass Spectrometry: Beyond Fungal Species Identification.Use of the MALDI BioTyper system with MALDI-TOF mass spectrometry for rapid identification of microorganisms.Susceptibility Testing of Fungi to Antifungal DrugsSusceptibility Testing of Bacteria Using Maldi-Tof Mass SpectrometryThe State-of-the-Art Mycology Laboratory: Visions of the Future
P2860
Q26749601-CC62F8CC-AA5B-40BF-9930-B6253CF3DCB1Q30459288-D85E4D14-942F-479F-8E20-E957216669DBQ33527403-A5627762-DF4E-4F02-99C6-1EA78E391732Q33725726-0B69D2AD-E61D-47DF-814F-7C745A17157DQ33808605-73D970BC-4DC1-498F-B07F-C08331F1D851Q33973352-3DE9D166-D2E3-45EE-8ADA-44098C261F7FQ34246802-65846B01-1B29-4F49-9728-43F4ECBC428FQ34306260-438A87D0-D9E6-4ACC-AF16-EB712036F5A8Q34337477-05D50622-E794-4798-9830-2468476618D5Q34342514-BDBA08CB-75F9-4CD8-8A89-0FD1CF83C616Q34529370-001FFF7A-197C-4AF8-95C7-07FD2524D365Q34593760-C5CF941D-67F3-48B6-B087-0FB3408DB01FQ34662276-36D94514-9E13-43DF-9E2E-3952AA3A5EE8Q34793588-47E3250B-BEB9-49E7-B9A6-C9F3EA38D850Q35016718-E2762972-4B5A-4117-AB28-E967897FA4D6Q35202737-D6E5BF86-4750-49B5-8E42-2DBD6A9F0A8EQ35597080-39A33C6B-C9A4-4AA2-8176-4CB0839B367CQ35688413-9B76EEBA-B794-4D17-8522-0ED179EDFEDDQ35689161-567ACC42-FBF4-4D0D-AA6C-DE73A95D0102Q35953421-C9F2EE4A-F3C2-47B5-AA87-2852AD5B0E46Q35984691-84914193-A4A5-4E3D-8E21-46059EEF9ECBQ36345309-7E534D32-33DE-4CCE-855B-EFF1A09E0FFAQ38088958-7171DD6C-C392-4B1D-AE35-DAFA65B68ED2Q38258833-4D77B24A-2DE3-4D6C-9191-936A09927E1FQ38824041-835B422E-16C4-4440-8163-C701D880D337Q40045673-0C494442-8E86-4A52-89FA-C2533212DCA8Q46290680-D02869C7-2E2F-4155-B09B-FF4C6CFE9EBCQ47706902-BA2BF71F-5490-4E93-91EC-419D92E11F3BQ51045332-AD4DF52A-BAC4-4BC9-8C09-FD41CACF09EEQ58737037-7BDF3BEE-BDF1-492F-AD41-B08C441DD29BQ58799053-93DFD27E-BE3C-4EE5-B531-0DC008E4DBECQ59294372-897A0A2F-3C78-44DD-9EED-C29CC9A14A70
P2860
MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
MALDI-TOF MS-based drug suscep ...... dida albicans and fluconazole.
@ast
MALDI-TOF MS-based drug suscep ...... dida albicans and fluconazole.
@en
type
label
MALDI-TOF MS-based drug suscep ...... dida albicans and fluconazole.
@ast
MALDI-TOF MS-based drug suscep ...... dida albicans and fluconazole.
@en
prefLabel
MALDI-TOF MS-based drug suscep ...... dida albicans and fluconazole.
@ast
MALDI-TOF MS-based drug suscep ...... dida albicans and fluconazole.
@en
P2093
P50
P356
P1433
P1476
MALDI-TOF MS-based drug suscep ...... dida albicans and fluconazole.
@en
P2093
Annick Datry
Arnaud Fekkar
Carine Marinach
Christophe Hennequin
Dominique Mazier
Jean-Louis Golmard
Jean-Yves Brossas
Martine Palous
Sophie Brun
Stéphanie Kwasek
P304
P356
10.1002/PMIC.200900152
P577
2009-10-01T00:00:00Z